tiprankstipranks

Trinity Biotech Secures Continued U.S. Government Funding for HIV Testing

Story Highlights
Trinity Biotech Secures Continued U.S. Government Funding for HIV Testing

Confident Investing Starts Here:

Trinity Biotech ( (TRIB) ) has issued an announcement.

Trinity Biotech announced a positive update regarding the U.S. government’s funding for HIV testing programs using their rapid HIV tests. On February 1, 2025, the U.S. Department of State confirmed a waiver that ensures continued funding under the President’s Emergency Plan for AIDS Relief, allowing the company to maintain its operations in this critical area.

More about Trinity Biotech

Trinity Biotech is a commercial-stage biotechnology firm based in Ireland, focusing on human diagnostics and diabetes management solutions, including wearable biosensors.

YTD Price Performance: -5.16%

Average Trading Volume: 2,223,627

Technical Sentiment Consensus Rating: Buy

Current Market Cap: $10.23M

For detailed information about TRIB stock, go to TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App